CINP Sumitomo Pharma Brain Health Basic Research Award
The Neuroscience Basic Research Award will be presented at the 35th CINP World Congress in Tokyo, Japan to a scientist for work in the field of basic research focusing on any neuropsychiatric disorders (eg schizophrenia, depression, OCD, etc).
CINP Sumitomo Pharma Brain Health Clinical Research AwardThe Neuroscience Clinical Research Award will be presented at the 35th CINP World Congress in Tokyo, Japan for work in the field of clinical research focusing on any neuropsychiatric disorders (eg schizophrenia, depression, OCD, etc).
Prize
The recipient of the 2024 award will be chosen by an international scientific jury.
- a monetary award of USD 10,000
- complimentary registration to CINP2024 in Tokyo
- an engraved plaque
Guidelines
-
The CINP Sumitomo Pharma Brain Health Basic and Clinical Research Awards are given to recognize a scientist’s outstanding contribution to psychopharmacology in the field of basic and clinical research.
-
Candidates must be less than 55 years of age as of 31st December 2024.
-
Candidates must be nominated by a member of CINP.
-
The candidate should be affiliated with a hospital, university, or research institute. If successful, the candidate must commit to attending the 2024 World Congress.
Application
CINP Sumitomo Pharma Brain Health Basic Research Award - Application form CINP Sumitomo Pharma Brain Health Clinical Research Award - Application form
Members wishing to nominate a candidate, should complete and submit the corresponding application form by 15th September 2023 to info@cinp.org along with: - Candidate’s Curriculum Vitae
- Nomination statement of up to 500 words, outlining the reasons that the candidate is a worthy recipient of the award.
- A summary not exceeding two double-spaced A4 pages outlining the significance of the candidate’s contribution to the field of psychopharmacology.
- Up to five (5) published articles that exemplify the candidate’s achievements in the field.
Previous Winners - Clinical
- 2023: Hidenori Yamasue, Hamamatsu University School of Medicine, Japan
- 2022: Celso Arango, Universidad Complutense Madrid, Spain
- 2020: Gustavo Turecki, McGill University, Canada
- 2016: Andreas Meyer-Lindenberg, Central Institute of Mental Health, Germany
- 2014: Eduard Vieta, Hospital Clinic of Barcelona, Spain
- 2010: Paul J. Harrison, University of Oxford, UK
- 2008: Rainer Rupprecht, University of Munich, Germany
- 2006: Michael Davidson, Sheba Medical Center, Israel
- 2004: Dennis S. Charney, National Institute of Mental Health, USA
- 2002: Jeffrey Lieberman, University of North Carolina at Chapel Hill, USA
| | |